Science ❯ Biomedicine

Immunology

Vaccine Development Vaccine Research Antibody Production Cancer Immunotherapy Allergen-Specific IgE Immunotherapy Immune System T Cell Responses Immune Tolerance Research Institutions Autoimmunity Antibody Treatments Clinical Applications Research Ethics Oncology T Cell Response Mucosal Immunity Stress Response

Generate Biomedicines Prices $400 Million IPO at $16 Ahead of Today’s Nasdaq Debut

Proceeds will support an AI-driven protein therapeutics pipeline led by the late-stage asthma drug GB-0895.

Infant Study Reveals Divergent Immune Responses to RSV and COVID-19 With Treatment Implications

Autoimmune Treatment Turns to Immune Reprogramming as Early Trials Deliver Remissions

Nanoparticle 'Super Adjuvant' Vaccine Blocks Multiple Cancers in Mice

David Baltimore, Nobel Laureate Who Discovered Reverse Transcriptase, Dies at 87

Mount Sinai Team Publishes MARQO, AI Pipeline for Faster Whole-Slide Cancer Tissue Analysis

Floss-Based Vaccine Shows Promise in Mice and Human Gumline Test

IL-12 Adjuvant in mRNA Vaccines Strengthens CD8+ T Cell Immunity and Broadens Protection